|

Seclidemstat Clinical Trials

1 actively recruiting trial across 1 location

Also known as: LSD1 Inhibitor SP-2577, SP 2577, SP-2577, SP2577

Pipeline

Phase 1/2: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Chronic Myelomonocytic Leukemia-01
  • Chronic Myelomonocytic Leukemia-21
  • Chronic Myelomonocytic Leukemia-11
  • Recurrent Myelodysplastic Syndrome1
  • Recurrent Chronic Myelomonocytic Leukemia1

Houston, Texas1 trial

Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

M D Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.